Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0439 Transporter Info
Gene Name SLC65A2
Transporter Name Niemann-Pick C1-like protein 1
Gene ID
29881
UniProt ID
Q9UHC9
Microbiota Influence of This DT (MBI)

Bacteria: Verrucomicrobiota

   Genus: Akkermansia

     Akkermansia muciniphila 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of SLC65A2 expression in metabolic dysfunction-associated fatty liver disease condition [1]

Studied Phenotype

 Metabolic dysfunction-associated fatty liver disease [ICD11: DB95]

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6 mice

Detailed Description

 The Akkermansia muciniphila ATCC BAA-835 has been reported to increase the expression of the drug transporter SLC65A2.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of SLC65A2 expression in the health condition [2] , [3]

Regulating Factor
Trimethylamine oxide

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite trimethylamine oxide generated from the metabolism of l-carnitine by the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC65A2.

       Microbe Influence 2

 Down regulating of SLC65A2 expression in the health condition [4]

Regulating Factor
Trimethylamine oxide

Studied Tissue

 Small intestine

In Vivo Model

 Sprague-Dawley rats

Detailed Description

 The metabolite trimethylamine oxide generated from the metabolism of l-carnitine by the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC65A2.

       Microbe Influence 3

 Down regulating of SLC65A2 expression in the health condition [5]

Studied Tissue

 Small intestine

In Vivo Model

 C57BL/6 mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC65A2.
References
1 Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 2021 Jan-Dec;13(1):1-19.
2 Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med. 2019 Sep;12(9):421-429.
3 Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013 May;19(5):576-85.
4 Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. World J Gastroenterol. 2019 May 28;25(20):2450-2462.
5 Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism. Nature. 2018 Feb 8;554(7691):255-259.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.